CureVac launches second stage of vaccine clinical trials in Peru and Panama
The German pharmaceutical company CureVac announced that it has started Phase 2 clinical trials of its experimental vaccine against Covid-19, a study that will be carried out in Peru and Panama. A first participant was vaccinated applying the technology CureVac has specialized, based on messenger RNA molecules (mRNA) found in the human body, the Tübingen […]